IDVOther than small business
IDC (multiple-award IDV) HHSO100201300006IAMGEN USA INC
Overview
Award facts
- Obligated on orders under this IDV
- $350.08M
- $350,075,298 across 4 orders
- Period of performance
- From Jul 11, 2018
- Modifications
- 2
- Latest action Jul 11, 2018
- Contract type
- IDC (multiple-award IDV)
- PIID HHSO100201300006I
Description of requirement
IGF::OT::IGF
Dates and value
- Award date
- Signed on Sep 19, 2013
- Ordering period ends
- Sep 18, 2018
- Ceiling
- Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $814,652,519
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 11, 2018. View on USAspending · Recipient on SAM.gov
Recipient
NameAMGEN USA INC
LocationTHOUSAND OAKS, CA
UEIXPGNQMXHP493
CAGE code5YNZ4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyAMGEN INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- 12100SOL00016(as reported)
Contract details
- Subcontracting plan
- Plan required - incentive includedD
- Major program
- Acquisition of a colony stimulating factor (g- or gm-csf) as a medical countermeasure for neutropeni
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Supplies or services pursuant to FAR 12.102(F)B
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- Yes
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Transaction history
Modification history
- Base award
- Sep 19, 2013Base obligation at award: $500,000
- Latest action
- Jul 11, 2018 — Other administrative actionModification 2; administrative: no change in scope or value
- Actions by type
- Base award1
- Novation (contract transferred)1
- Other administrative action1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- FAR 52.223-4 and FAR 52.223-9 includedB
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / indefinite quantityB
- Multiple or single award
- Multiple awardM
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501